Inhibrx
INBX
$34.12
Share price
0.09%
Change (1 day)
70.77%
Change (1 year)
Categories
Market capitalization of Inhibrx (INBX)
Market cap: $1.61 Billion
As of April 2024 Inhibrx has a market cap of $1.61 Billion. This makes Inhibrx the world's 4449th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Inhibrx from 2020 to 2024
End of year Market Cap
| Year | Market cap | Change |
|---|---|---|
| 2024 | $1.61 B | -10.02% |
| 2023 | $1.79 B | 67.46% |
| 2022 | $1.07 B | -35.26% |
| 2021 | $1.65 B | 33.31% |
| 2020 | $1.24 B |
End of Day market cap according to different sources
On Apr 25th, 2024 the market cap of Inhibrx was reported to be:
$1.61 Billion
$1.61 Billion
$1.61 Billion
$1.61 Billion
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $0.53 B | -66.63% | 🇺🇸 USA |